Andrew Boll
@andrewboll
Executive Officer
Building Imprimis Pharmaceuticals, Inc. as Executive Officer
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Eton Pharmaceuticals, Inc. was founded in 2017 and has no closure on record.
Named alongside
- Charles CasamentoDirector
- Charles J CasamentoDirector
- Mark BaumDirector
- Mark L. BaumDirector
- Norbert G RiedelDirector
- PAUL V. MAIERDirector
- Sean BrynjelsenExecutive Officer, Director
- William Wilson TroutmanExecutive Officer
At Imprimis Pharmaceuticals, Inc.
- Andrew R BollExecutive Officer
- Andrew R. BollExecutive Officer
- Anthony PrincipiDirector
- Mark BaumExecutive Officer, Director
- Mark L. BaumExecutive Officer, Director
- Richard LindstromDirector
- Richard L. LindstromDirector
- R Larry Van HornDirector
- Brad OsborneExecutive Officer
- Gregory MadisonExecutive Officer, Director
- John BerdahlDirector
- Larry DillahaDirector
- Mark BaumDirector
Contribution
Andrew's ideas, decisions and failures appear here once this profile is claimed.
Companies
- Imprimis Pharmaceuticals, Inc.Pharmaceutical Preparations; formerly HARROW HEALTH, INC.; listed on Nasdaq as HROW; filing with the SEC since 2006Executive Officer · Pharmaceuticals · SAN DIEGO, United States
- Eton Pharmaceuticals, Inc.Pharmaceutical Preparations; listed on Nasdaq as ETON; filing with the SEC since 2017Director · Pharmaceuticals · SAN DIEGO, United States · Founded 2017
- Melt Pharmaceuticals, Inc.Pharmaceutical Preparations; filing with the SEC since 2019Director · Pharmaceuticals · SAN DIEGO, United States · Founded 2018